Use ICON to protect against small markets fluctuations. The stock experiences normal downward trend, but the immediate impact on correlations cannot be determined at the moment
Bruce Given Non-Executive Chairman of the Board, Ph.D
Ciaran Murray CEO, Director and Chairman of Execution Sub-Committee
Stephen Cutler Group President - Clinical Research Services
ICON Price and Market Media
The median price of ICON for the period between Wed, Apr 24, 2013 and Fri, May 24, 2013 is 32.5 with a coefficient of variation of 3.05. The daily time series for the period is distributed with a sample standard deviation of 0.99, arithmetic mean of 32.51, and mean deviation of 0.69. The Stock did not receive any noticable media coverage during the period.
ICON Public Limited Company [ICLR] is traded on NASDAQ in USA. It is located in Dublin, and employs 10,200 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 2.01 B. ICON Public Limited Company conducts business under Healthcare sector and is part of Medical Laboratories and Research industry. This company has 60.54 M outstanding shares of which 676.83 K shares are currently shorted by private and institutional investors with about 1.1 trading days to cover.
ICON Public Limited Company, a contract research organization, offer outsourced development services to the pharmaceutical, biotechnology, and medical device industries primarily in Ireland, the United States, and rest of Europe. more
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated.
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory
-0.29% 
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Advice
Nasdaq
